Related Experiment Video
Updated: Aug 17, 2026

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
Published on: June 9, 2014
Renal osteodystrophy
1Department of Pediatrics, Children's Hospital of Michigan, Detroit 48201, USA.
Insights
Secondary hyperparathyroidism in chronic renal failure causes bone disease in children. Treatment involves managing phosphate, calcium, and vitamin D levels to improve outcomes.
Area of Science:
- Nephrology
- Endocrinology
- Pediatrics
Background:
- Secondary hyperparathyroidism is common in chronic renal failure (CRF).
- It is histologically linked to osteitis fibrosa cystica.
- This condition causes significant growth failure and bone deformities in children.
Purpose of the Study:
- To summarize the pathogenesis and treatment of secondary hyperparathyroidism in CRF.
- To highlight its impact on pediatric bone health.
Main Methods:
- Review of the pathophysiology of renal osteodystrophy.
- Discussion of treatment strategies for secondary hyperparathyroidism in CRF.
Main Results:
- Phosphate retention, altered calcium and calcitriol metabolism are key factors.
- Metabolic acidosis, cytokines, and parathyroid hormone degradation also contribute.
- Effective treatment requires a multi-faceted approach.
Conclusions:
- Secondary hyperparathyroidism in CRF leads to severe bone disease, particularly in children.
- Management focuses on dietary phosphate restriction, phosphate binders, and vitamin D metabolites.
Abstract:
Secondary hyperparathyroidism develops in most patients with chronic renal failure, and is associated with the histologic finding of osteitis fibrosa cystica. The disease is characterized by growth failure and severe bone deformities in children, especially the very young. The pathogenesis of renal osteodystrophy is related to phosphate retention, and its effect on calcium and calcitriol metabolism, in addition to roles played by metabolic acidosis, cytokines, and degradation of parathyroid hormone. Treatment includes restriction of dietary phosphorous intake, phosphate binders, and use of active metabolites of vitamin D.
Related Concept Videos
What is the Skeletal System?
Bone Remodeling
Osteoclasts in Bone Remodeling
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Bone Remodeling and Repair

